Susmed (TSE:4263) EBIT : 円43.6 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Susmed EBIT?

Susmed's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was 円52.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was 円43.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Susmed's annualized ROC % for the quarter that ended in Dec. 2023 was 95.83%. Susmed's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Susmed's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1.06%.

Susmed EBIT Historical Data

The historical data trend for Susmed's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Susmed EBIT Chart

Susmed Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

EBIT

-160.73

-333.42

-229.15

-48.32

Susmed Quarterly Data
	Jun20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial							-97.76	278.84	-137.61	-150.44	52.85

Competitive Comparison of Susmed's EBIT

For the Health Information Services subindustry, Susmed's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Susmed's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Susmed's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Susmed's EV-to-EBIT falls into.

Susmed EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円43.6 Mil.

Susmed (TSE:4263) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Susmed's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	211.38 * ( 1 - 0.55% )	/	( (151.684	+	287.063)	/ 2 )
=	210.21741	/	219.3735
=	95.83 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4942.58	-	62.695	-	( 4890.275	-	max(0, 198.646	-	4926.847	+	4890.275	))
=	151.684

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	5172.011	-	76.263	-	( 5081.649	-	max(0, 324.814	-	5133.499	+	5081.649	))
=	287.063

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Susmed's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	211.38	/	( ( (0 + max(-162.074, 0))	+	(0 + max(-272.964, 0)) )	/	2 )
=	211.38	/	( ( 0	+	0 )	/	2 )
=	211.38	/	0
=	%

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(11.975	+	0	+	24.597)	-	(62.695	+	0	+	135.951)
=	-162.074

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(10.413	+	0	+	41.437)	-	(76.263	+	0	+	248.551)
=	-272.964

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Susmed's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	43.631	/	4101.913
	=	1.06 %

Susmed EBIT Related Terms

Thank you for viewing the detailed overview of Susmed's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Susmed (TSE:4263) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Susmed Inc (TSE:4263) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-7-2, Honcho, Nihombashihoncho, Chuo-ku, Tokyo, JPN, 103-0023

Website

https://www.susmed.co.jp

Susmed Inc is engaged in the development of medical equipment and software systems Collection and distribution of medical information.

Susmed (TSE:4263) Headlines

No Headlines